EP2670424 - CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 04.11.2015 Database last updated on 11.05.2024 | Most recent event Tooltip | 04.11.2015 | Withdrawal of application | published on 02.12.2015 [2015/49] | Applicant(s) | For all designated states Fate Therapeutics, Inc. Suite 200, 3535 General Atomics Court San Diego, California 92121 / US | [2013/50] | Inventor(s) | 01 /
LEE, Tom Tong 9308 Galvin Avenue San Diego, California 92126 / US | 02 /
LAI, Kevin 8233 Station Village Lane Unit 2305 San Diego, CA 92108 / US | 03 /
MENDLEIN, John 1550 Neptune Ave. Encinitas, CA 92024 / US | 04 /
FLYNN, Peter 611 Sea Lane La Jolla, CA 92037 / US | [2013/50] | Representative(s) | Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB Ganghoferstraße 68 B 80339 München / DE | [N/P] |
Former [2013/50] | Schiweck, Weinzierl & Koch European Patent Attorneys Landsberger Straße 98 80339 München / DE | Application number, filing date | 12741723.6 | 01.02.2012 | WO2012US23534 | Priority number, date | US201161438581P | 01.02.2011 Original published format: US 201161438581 P | US201161438607P | 01.02.2011 Original published format: US 201161438607 P | US201161439803P | 04.02.2011 Original published format: US 201161439803 P | US201161439801P | 04.02.2011 Original published format: US 201161439801 P | [2013/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2012106463 | Date: | 09.08.2012 | Language: | EN | [2012/32] | Type: | A2 Application without search report | No.: | EP2670424 | Date: | 11.12.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.08.2012 takes the place of the publication of the European patent application. | [2013/50] | Search report(s) | International search report - published on: | KR | 20.12.2012 | (Supplementary) European search report - dispatched on: | EP | 01.12.2014 | Classification | IPC: | A61K38/17, A61K38/16, C07K14/47, A61P29/00, A61K38/00, C07K14/52 | [2015/01] | CPC: |
C07K14/52 (EP,US);
A61P1/16 (EP);
A61P29/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
A61K38/00 (EP,US)
(-)
|
Former IPC [2013/50] | A61K38/17, A61K38/16, C07K14/47, A61P29/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/50] | Title | German: | CARDIOTROPHIN-VERWANDTE MOLEKÜLE FÜR VERBESSERTE THERAPEUTIKA | [2013/50] | English: | CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS | [2013/50] | French: | MOLÉCULES LIÉES À LA CARDIOTROPHINE POUR THÉRAPEUTIQUE AMÉLIORÉE | [2013/50] | Entry into regional phase | 30.08.2013 | National basic fee paid | 30.08.2013 | Search fee paid | 30.08.2013 | Designation fee(s) paid | 30.08.2013 | Examination fee paid | Examination procedure | 30.08.2013 | Examination requested [2013/50] | 29.06.2015 | Amendment by applicant (claims and/or description) | 26.10.2015 | Application withdrawn by applicant [2015/49] | Fees paid | Renewal fee | 27.02.2014 | Renewal fee patent year 03 | 26.02.2015 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2009042795 (FERNANDO PASAN [CA], et al) [A] 1-15* claim 8 * | International search | [A]US5624806 (BAKER JOFFRE [US], et al); | [A]US2004018586 (ROSENDAHL MARY S [US], et al); | [A]US7253267 (COX III GEORGE N [US]); | [X] - PROTEIN, (20100601), Database accession no. XP_001103315, XP055120816 |